drugset / Trial / NCT07451665
Efficacy and Safety of Vunakizumab and Ivarmacitinib in the Treatment of Active Takayasu's Arteritis
RandomizedParallel-groupOpen-labelTreatment
Summary
This is a prospective, open-label, controlled, multiple centers, randonmized clinical trial. It compares the clinical efficacy and safety of vunakizumab ivarmacitinib and glucocorticoids in the treatment of active Takayasu's arteritis.
Timeline
- Start
- 2026-04-01
- Primary completion
- 2029-03-31
- Completion
- 2029-03-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Prednisone | Other / unclassified | — | — |
| Subject | SHR0302 | Unknown | 8 mg | Oral |
| Subject | Vanakizumab | Unknown | 240 mg | Subcutaneous |